Want to see IN:DIVISLAB full AI Analyst Report?
Divi's Laboratories Limited (DIVISLAB) Revenue
Divi's Laboratories Limited Revenue
Divi's Laboratories Limited had a revenue of 30.80B in the quarter ending Jun 30, 2026, with 8.80%. This bring the company's revenue in the last twelve months to 112.30B, Increased 6.34%. In the fiscal year ending Mar 31, 2026, Divi's Laboratories Limited had annual revenue of 105.60B with 13.24% growth.
- Revenue (ttm)
- 112.30B
- Revenue Growth
- 16.35%
- P/S Ratio
- 24.42
- Revenue/Employee
- INR 9,130,999
- Employees
- 11,565
- Market Cap
- INR 2.58T
Revenue Chart
Divi's Laboratories Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 105.60B | 12.35B | 13.24% |
| Mar 31, 2025 | 93.25B | 15.29B | 19.61% |
| Mar 31, 2024 | 77.96B | 1.31B | 1.71% |
| Mar 31, 2023 | 76.65B | -11.34B | -12.89% |
| Mar 31, 2022 | 87.99B | 19.41B | 28.30% |
| Mar 31, 2021 | 68.58B | 15.67B | 29.62% |
| Mar 31, 2020 | 52.91B | 4.87B | 10.15% |
| Mar 31, 2019 | 48.04B | 9.96B | 26.17% |
| Mar 31, 2018 | 38.07B | -2.46B | -6.07% |
| Mar 31, 2017 | 40.53B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:DIVISLAB | 112.30B |
| IN:AUROPHARMA | 348.91B |
| IN:DRREDDY | 329.84B |
| IN:GRANULES | 56.18B |
| IN:LAURUSLABS | 72.70B |
| IN:NEULANDLAB | 23.72B |